引用次数
引用: 4,982
H-指数: 24
I10-指数 : 43
出版物: 147
The NCRI Myeloma XI trial for newly diagnosed symptomatic multiple myeloma (NDMM); second primary malignancy (SPM) incidence when lenalidomide is used as an induction and maintenance treatment option
MT Drayson , C Pawlyn , M Kaiser , W Gregory
XXXVI World Congress of the International Society of Hematology
2016
Recent Progress in Interferon Therapy for Myeloid Malignancies
Simona Soverini , Ken Mills , Fabio Stagno , John F Woolley
Insights in Hematologic Malignancies: 2021
2022
Limnological characteristics of Lake of the Ozarks, Missouri II: Measurements following formation of
JoHN R JoNEs , MARK S KAIsER
Limnology of a wetland complex in the Mississippi
GLENN D WvLE , JoHN R JoNEs
1) partment of Animal 1 cology. lowa State University. Ancs, lowa 500 1
John R JONES , Roger W BAC'H
Environmental limits to a rapidly spreading
John R JONES
Lenalidomide Maintenance Significantly Improves Outcomes Compared to Observation Irrespective of Cytogenetic Risk: Results of the Myeloma XI Trial
Mark T Drayson , Charlotte Pawlyn , Walter M Gregory , Martin F Kaiser
Blood 130 436 -436
16
2017
Minimal Residual Disease in the Maintenance Setting in Myeloma: Prognostic Significance and Impact of Lenalidomide
Mark T Drayson , Andy Rawstron , Ruth M de Tute , Charlotte Pawlyn
Blood 130 904 -904
7
2017
Factors Predicting Poor Outcomes for Myeloma Patients at Different Ages: Results from 3894 Patients in the Myeloma XI Trial
Mark T Drayson , Charlotte Pawlyn , Walter M Gregory , Martin F Kaiser
Blood 130 3040 -3040
2
2017
Continuous Treatment with Lenalidomide Improves Outcomes in Newly Diagnosed Myeloma Patients Not Eligible for Autologous Stem Cell Transplant: Results of the Myeloma XI Trial
Mark T Drayson , Charlotte Pawlyn , Walter M Gregory , Martin F Kaiser
Blood 130 1854 -1854
4
2017
The Mutational Landscape of Relapse in High Risk Myeloma Is Significantly Impacted By the Depth of Response but Not Maintenance Lenalidomide
Mark T Drayson , Amy L Sherborne , Charlotte Pawlyn , Charlotte Pawlyn
Blood 130 396 -396
1
2017
Mutations in CRBN and Other Cereblon Pathway Genes Are Only Associated with Acquired Resistance to Immunomodulatory Drugs in a Subset of Patients and Cell Line Models
Charlotte Pawlyn , Charlotte Pawlyn , Rajesh Chopra , Niels Weinhold
Blood 136 6 -7
2020
Molecular Characterisation of TP53 Aberrations in 1,777 Myeloma Trial Patients
Mark T Drayson , Amy L Sherborne , Charlotte Pawlyn , Walter M Gregory
Blood 130 4331 -4331
1
2017
Maximizing Pre-Transplant Response Is Associated with Improved Outcome for Myeloma Patients: Exploratory Analysis of the Myeloma XI Trial
Charlotte Pawlyn , Graham H Jackson , David Cairns , Alina Striha
Blood 132 3280 -3280
2018
Spatiotemporal Analysis of Intraclonal Heterogeneity in Multiple Myeloma: Unravelling the Impact of Treatment and the Propagating Capacity of Subclones Using Whole Exome Sequencing
Lorenzo Melchor , John R Jones , Oleg Lenive , Erich Allen Peterson
Blood 126 ( 23) 371 -371
4
2015
Molecular Subgroups of Hyperdiploidy and Their Prognostic Relevance - an Analysis of 1,036 Myeloma Trial Patients
Martin F Kaiser , Eileen Mary Boyle , Brian A Walker , Dil B Begum
Blood 126 ( 23) 2983 -2983
2015
Specific Identification of High Risk Disease Using Molecular Profiling By Mymap (Myeloma MLPA and translocation PCR) of 1,036 Cases
Martin F Kaiser , Eileen Mary Boyle , Brian A Walker , Dil B Begum
Blood 126 ( 23) 2981 -2981
2015
The Addition of Carfilzomib to a Lenalidomide-Based Triplet Improves Outcomes in Newly Diagnosed Transplant Eligible Myeloma Patients with Renal Impairment: A Subgroup Analysis of the Myeloma XI Trial
Charlotte Pawlyn , Tom Menzies , Faith E. Davies , Ritika Rana
Blood 136 40 -43
2020
Lenalidomide Is a Highly Effective Maintenance Therapy in Myeloma Patients of All Ages; Results of the Phase III Myeloma XI Study
Graham H Jackson , Faith E Davies , Charlotte Pawlyn , David A Cairns
Blood 128 ( 22) 1143 -1143
22
2016
Primary IMiD Refractory Myeloma; Results from 3894 Patients Treated in the Phase III Myeloma XI Study
Walter M Gregory , Graham H Jackson , Gareth J Morgan , Charlotte Pawlyn
Blood 128 ( 22) 1144 -1144
2
2016